ImmunoPrecise Antibodies Announces an Unprecedente
Seite 1 von 1 Neuester Beitrag: 29.03.20 17:39 | ||||
| Eröffnet am: | 20.06.19 15:59 | von: AWSX | Anzahl Beiträge: | 3 |
| Neuester Beitrag: | 29.03.20 17:39 | von: calimera | Leser gesamt: | 4.267 |
| Forum: | Börse | Leser heute: | 3 | |
| Bewertet mit: |  | |||
Hübscher Chart (kürzlich Golden Cross) und News stehen an - Handel drüben ausgesetzt, auf L&S grad eben noch ein paar Stücke geschossen.
Schaun wir mal...
https://twitter.com/search?q=%24IPA.V&src=cashtag_click&f=live
"EVQLV is working on the advancement with Immunoprecise Antibodies (IPA), a bioscience research company concentrating on discovering therapeutic antibodies.
The collaboration “will accelerate the effort to develop therapeutic candidates against COVID-19,” according to the news report. “EVQLV will identify and screen hundreds of millions of potential antibody treatments in only a few days—far beyond the capacity of any laboratory.”
With the algorithmic screening complete, IPA will produce and test the most promising antibody candidates..."
https://www.aiin.healthcare/topics/...ce-covid-19-treatment-discovery